Curing Leukaemia


Wed, Mar 18th, 2015 10:00 by capnasty NEWS

Although still at the early stages of research, two possible methods for curing leukaemia have been announced. The first involves releasing DNA nanobots that only attack cancer cells.

A human patient with late stage leukemia will be given DNA nanobot treatment. Without the DNA nanobot treatment the patient would be expected to die in the summer of 2015. Based upon animal trials they expect to remove the cancer within one month.

The second involves mutating leukaemia cells into macrophages — harmless immune cells — and then putting them to work against the cancer itself.

“B-cell leukemia cells are in many ways progenitor cells that are forced to stay in an immature state,” Majeti said. So he, McClellan and student Christopher Dove, an MD/PhD student and the paper’s other lead author, did more experiments and confirmed that methods shown to have altered the fate of the mouse progenitor cells years ago could be used to transform these human cancer cells into macrophages, which can engulf and digest cancer cells and pathogens.



You may also be interested in:

IBM's Watson Saves the Life of Patient by Correctly Indentifying Her Disease
Hospitals to Use Credit Card Data to Determine Which Patient Will Get Sick
"Cancer immunotherapy is currently causing significant excitement in the medical community."
One-Time Injection Could Reduce Cholesterol Levels Forever